The agtech group’s protein-based biocontrol technology has demonstrated promising laboratory results against insect molecular targets
Agtech group Biotalys has announced it has achieved a first research milestone in its partnership with Syngenta, to develop a novel bioinsecticide against key insect pests.
According to Biotalys, initial laboratory tests demonstrated ”promising in vitro results” with novel bioactive ingredients developed using its Agrobody technology against the insect molecular target.
“Biotalys is dedicated to developing regenerative crop protection solutions that combine the efficacy of conventional products with the sustainability benefits of biologicals,” said Carlo Boutton, interim CEO of Biotalys.
”Working with industry leaders like Syngenta enables us to accelerate the path from research to the field.
”This first milestone is an important step in validating the potential of our technology platform in insect control, and we look forward to continuing our work with our partner to deliver novel, differentiated modes of action that can be seamlessly integrated into growers’ integrated pest management programs to expand the range of effective tools available to them,” he added.
As insect resistance continues to rise alongside tightening regulatory and environmental constraints, growers are increasingly seeking new solutions that remain effective over time while reducing environmental impact, the group pointed out.
Biotalys emphasised that its protein‑based biocontrols offer a new class of crop protection active ingredients that support growers in managing resistant insect populations while offering a targeted, safe and sustainable approach to crop protection.
The teams from both companies will proceed to the next research phase, it confirmed, testing active ingredients on living organisms (in vivo).
Syngenta will pay Biotalys a first milestone, reflecting continued progress in the collaboration while not materially impacting Biotalys’ current cash runway.
